It is a prescription therapy that can be highly effective when it is used for the right patient, under the right indication, with the right follow-up and the right lifestyle foundation
those on GLP-1s find that it helps with constipation in particular
For example, the DURATION-8 study demonstrated that mean bodyweight loss with the combination of exenatide (GLP1-RA, which suppresses appetite) once weekly and dapagliflozin (SGLT2 inhibitor) once daily in patients with T2D was greater than that with the monotherapies alone [17]
AbbVies corporate value through the Humira cliff was maintained not by the residual Humira patent estate, but by the accumulated clinical and commercial data supporting Skyrizi and Rinvoq, each of which has its own IP stack
These medications: Improve insulin sensitivity and lower A1C
Duration varies based on your goals and medical evaluation